Track topics on Twitter Track topics that are important to you
4.4 million children and adolescents in the United States have been diagnosed with attention deficit hyperactivity disorder (ADHD) and more than half are treated with medication. Most ADHD medications are stimulants, which activate the sympathetic nervous system (SNS). SNS activation is closely associated with vascular functional and mechanical abnormalities. Therefore, ADHD medications, via instigating SNS activation and altering the hemodynamic profile, may have untoward effects on the vasculature and increase risk of developing cardiovascular disease in children and adolescents who use them. Our overall objective in this study is to determine whether ADHD medication use is associated SNS activation, endothelial dysfunction, and arterial stiffness in children and adolescents. We will address this objective by conducting a prospective, repeated measures, observational study and obtaining non-invasive measures of SNS activation, endothelial function, and arterial stiffness at baseline (prior to initiation of ADHD stimulant drug therapy) and at 6- and 12-months after initiation of therapy in 62 children and adolescents (8-17 years old) recruited from the University of Minnesota Pediatric Neurodevelopment Clinic.
SPECIFIC AIMS AND HYPOTHESES
Our overall objective in this study is to determine whether ADHD medication use is associated SNS activation, endothelial dysfunction, and arterial stiffness in children and adolescents.
Our hypotheses are:
1. Children and adolescents who initiate ADHD stimulant drug therapy will have increased SNS activation, as measured by heart rate variability, 6-months after initiating therapy. SNS activation will increase further at the 12-month time point.
2. Children and adolescents who initiate ADHD stimulant drug therapy will have decreased digital reactive hyperemia and increased pulse wave velocity and aortic augmentation index 6-months after initiating therapy. These changes in levels will be even more pronounced at the 12-month time point.
3. At the 6- and 12-month time points, the degree of SNS activation will be negatively correlated with digital reactive hyperemia and positively correlated with pulse wave velocity and aortic augmentation index in children and adolescents taking ADHD medication.
Study Design In this prospective, repeated measures, observational study we will obtain non-invasive measures of SNS activation (heart rate variability), endothelial function (digital reactive hyperemia), and arterial stiffness (carotid-radial pulse wave velocity; aortic augmentation index), at baseline (prior to initiation of ADHD stimulant drug therapy) and at 6- (± 7 days) and 12-months (± 7 days) after initiation of therapy.
Study visits will be conducted at the Clinical and Translational Science Institute (CTSI) at the University of Minnesota. All vascular testing will occur in the Vascular Biology Laboratory within the CTSI.
Observational Model: Case-Only, Time Perspective: Prospective
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Published on BioPortfolio: 2014-08-27T03:14:27-0400
The researchers plan to explore the validity of the category of ADHD NOS by identifying the risk for ADHD in the children of ADHD NOS adult probands and identifying common correlates of AD...
This will be an open label pilot study of Concerta in the treatment of adults with the diagnosis of Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS). We hypothes...
The purpose of this study is to understand the relationship between ADHD and the overall health of someone with ADHD. People who have ADHD have trouble paying attention, concentrating, org...
This study will evaluate the safety and effectiveness of methylphenidate in treating attention deficit hyperactivity disorder (ADHD) in children with both ADHD and trichotillomania. ...
This will be a 6-week, unblinded study using the medication Strattera for children and adolescents with attention deficit hyperactivity disorder (ADHD) who failed to respond to an adequate...
Extensive, yet disparate, research exists elucidating structural anomalies in individuals with Reading Disability (RD) or ADHD. Despite ADHD and RD being highly comorbid, minimal research has attempte...
Attention-deficit/hyperactivity disorder (ADHD), the most common pediatric neurobehavioral disorder, frequently presents with co-existing reading disorders (RD). Despite this, it is unclear whether me...
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder, characterized by age inappropriate and impairing levels of inattention and/or hyperactivity/impulsivity. Pharma...
Attention deficit hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder of childhood. It is primarily characterised by high levels of activity, inattention, and impulsivity, ...
The purpose of this study was to determine if changes in dental development are associated with Attention Deficit Hyperactivity Disorder (ADHD) or ADHD medications.
A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD.
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...